tiprankstipranks
Trending News
More News >
Pacira (PCRX)
:PCRX
US Market
Advertisement

Pacira Pharmaceuticals (PCRX) Technical Analysis

Compare
373 Followers

Technical Sentiment

Overall Consensus
Neutral
7Bullish
6Neutral
9Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Pacira’s (PCRX) Moving Averages Convergence Divergence (MACD) indicator is -0.65, suggesting Pacira is a Sell.
Pacira’s (PCRX) 20-Day exponential moving average is 22.22, while Pacira’s (PCRX) share price is $21.85, making it a Sell.
Pacira’s (PCRX) 50-Day exponential moving average is 23.31, while Pacira’s (PCRX) share price is $21.85, making it a Sell.

Pacira Pharmaceuticals (PCRX) Pivot Points

Nov 09, 2025, 11:26 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.16
19.90
20.50
21.24
21.84
22.58
23.18
Fibonacci
19.90
20.41
20.73
21.24
21.75
22.07
22.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pacira Pharmaceuticals (PCRX) Moving Averages

Nov 09, 2025, 11:26 AM
Period
Simple
Exponential
MA5
21.93Buy
21.77Buy
MA10
21.60Buy
21.80Buy
MA20
22.00Buy
22.22Sell
MA50
24.25Sell
23.31Sell
MA100
23.96Sell
23.79Sell
MA200
24.56Sell
23.53Sell
Pacira’s (PCRX) 10-Day exponential moving average is 21.80, while Pacira’s (PCRX) share price is $21.85, making it a Buy.
Pacira’s (PCRX) 100-Day exponential moving average is 23.79, while Pacira’s (PCRX) share price is $21.85, making it a Sell.
Pacira’s (PCRX) stock price is $21.85 and Pacira’s (PCRX) 50-day simple moving average is 24.25, creating a Sell signal.
Pacira’s (PCRX) stock price is $21.85 and Pacira’s (PCRX) 100-day simple moving average is 23.96, creating a Sell signal.
Pacira’s (PCRX) stock price is $21.85 and Pacira’s (PCRX) 200-day simple moving average is 24.56, creating a Sell signal.

Pacira Pharmaceuticals (PCRX) Technical Indicators

Nov 09, 2025, 11:26 AM
Name
Value
Implied Action
RSI (14)
45.64
Neutral
STOCH (9,6)
45.31
Neutral
STOCHRSI (14)
50.48
Neutral
MACD (12,26)
-0.65
Sell
ADX (14)
41.99
Neutral
Williams %R
-45.02
Buy
CCI (14)
14.00
Neutral
ATR (14)
1.17
-
Ultimate Oscillator
51.99
Neutral
ROC
-4.21
Sell
Pacira’s (PCRX) Relative Strength Index (RSI) is 45.64, creating a Neutral signal.
Pacira’s (PCRX) Trend Strength Indicator (ADX) is 41.99, creating a Neutral signal.
Pacira’s (PCRX) Commodity Channel Index (CCI) is 14.00, creating a Neutral signal.
Pacira’s (PCRX) Price Rate of Change (ROC) is -4.21, creating a Sell signal.

FAQ

Is PCRX a Buy, Hold, or Sell?
Based on PCRX’s technical indicators, PCRX is a Hold.
    What is PCRX’s RSI (14)?
    PCRX’s RSI (14) is 45.64, which suggests PCRX is a Neutral.
      What is PCRX’s MACD?
      PCRX’s MACD is -0.65, which suggests PCRX is a Sell.
        What is PCRX’s 5-day moving average?
        PCRX’s 5-day moving average is 21.93, which suggests PCRX is a Buy.
          What is PCRX’s 20-day moving average?
          PCRX 20-day moving average is 22.00, which suggests PCRX is a Buy.
            What is PCRX’s 50-day moving average?
            PCRX’s 50-day moving average is 24.25, which suggests PCRX is a Sell.
              What is PCRX’s 200-day moving average?
              PCRX’s 200-day moving average is 24.56, which suggests PCRX is a Sell.
                What is PCRX’s Williams % R (14)?
                PCRX’s Williams % R (14) is -45.02, which suggests PCRX is a Buy.
                  What is PCRX’s CCI (14)?
                  PCRX’s CCI (14) is 14.00, which suggests PCRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis